You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股異動丨NMN概念股再度爆發 機構稱千億市場未來可期
格隆匯3月21日丨NMN概念股再度爆發,爾康製藥、眾生藥業和康惠製藥漲停,金達威漲8.66%。艾瑞諮詢數據顯示,2020年中國NMN成分保健品市場規模達51.06億元,同比增長34.87%,預計到2023年將會以近70.25%的增速攀升至270.13億元,行業發展速度較快。中信證券此前發佈的研報指出,延長壽命作為人類終極問題之一,在全球經濟增長和人口老齡化不斷加重的背景下,市場關注度和規模持續提升,2019年全球抗衰老市場規模1900億美元,同比增長8.3%。中國市場近些年保健品行業發展迅速,行業過去10年複合增速9.5%。根據測算,當前國內每1%保健品人口對應的NMN市場空間為304億元,伴隨未來抗衰老產品不斷推廣,行業遠期市場有望達到千億規模。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account